259 related articles for article (PubMed ID: 33919088)
1. Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases.
Bungau S; Vesa CM; Abid A; Behl T; Tit DM; Purza AL; Pasca B; Todan LM; Endres L
Molecules; 2021 Apr; 26(9):. PubMed ID: 33919088
[TBL] [Abstract][Full Text] [Related]
2.
Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
[TBL] [Abstract][Full Text] [Related]
3. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.
Sivasankarapillai VS; Madhu Kumar Nair R; Rahdar A; Bungau S; Zaha DC; Aleya L; Tit DM
Environ Sci Pollut Res Int; 2020 Jul; 27(21):26025-26035. PubMed ID: 32405942
[TBL] [Abstract][Full Text] [Related]
4. Phytochemistry, Food Application, and Therapeutic Potential of the Medicinal Plant (
Khan MI; Maqsood M; Saeed RA; Alam A; Sahar A; Kieliszek M; Miecznikowski A; Muzammil HS; Aadil RM
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833974
[TBL] [Abstract][Full Text] [Related]
5. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
[TBL] [Abstract][Full Text] [Related]
6. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
[TBL] [Abstract][Full Text] [Related]
7. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog inhibitors from Withania somnifera.
Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
[TBL] [Abstract][Full Text] [Related]
9. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
11. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
12. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
13. Preparation, Characterization, and Pharmacological Investigation of Withaferin-A Loaded Nanosponges for Cancer Therapy; In Vitro, In Vivo and Molecular Docking Studies.
Shah HS; Nasrullah U; Zaib S; Usman F; Khan A; Gohar UF; Uddin J; Khan I; Al-Harrasi A
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834081
[TBL] [Abstract][Full Text] [Related]
14. Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component.
Dar PA; Singh LR; Kamal MA; Dar TA
Curr Pharm Des; 2016; 22(5):535-40. PubMed ID: 26601969
[TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationships of Withanolides as Antiproliferative Agents for Multiple Myeloma: Comparison of Activity in 2D Models and a 3D Coculture Model.
Freitas Misakyan MF; Wijeratne EMK; Issa ME; Xu YM; Monteillier A; Gunatilaka AAL; Cuendet M
J Nat Prod; 2021 Aug; 84(8):2321-2335. PubMed ID: 34445874
[TBL] [Abstract][Full Text] [Related]
16. Withania frutescens (L.) Pauquy, a valuable Mediterranean shrub containing bioactive withanolides.
Bouissane L; Bailly C
Steroids; 2024 Jul; 207():109439. PubMed ID: 38740121
[TBL] [Abstract][Full Text] [Related]
17. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug.
Hassannia B; Logie E; Vandenabeele P; Vanden Berghe T; Vanden Berghe W
Biochem Pharmacol; 2020 Mar; 173():113602. PubMed ID: 31404528
[TBL] [Abstract][Full Text] [Related]
18. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
Namdeo AG; Ingawale DK
J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
